ME-609: A treatment for recurrent herpes simplex virus infections

Antiviral Chemistry and Chemotherapy

Volumn 14, Issue 4, 2003, Pages 205-215

  Harmenberg, Johan G ^a,b   Awan, Aftab R ^a,c   Alenius, Stefan ^d   Ståhle, Lars ^e   Erlandsson, Anna C ^b   Lekare, Gunilla ^f   Flink, Ola ^g   Augustsson, Elisabeth ^a   Larsson, Torbjörn ^a   Wikström, Ann Charlotte ^b   Stierna, Pontus ^e   Field, Hugh J ^c   Larsson, Alf G ^g   Öberg, Bo ^a,b  

^a MEDIVIR AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NATIONAL VETERINARY INSTITUTE   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f CCS AB   (Sweden)

^g ASTRAZENECA R AND D   (Sweden)

Author keywords

Acyclovir; Animal models; HSV 1; Hydrocortisone; Immune response

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; HYDROCORTISONE; ME 609; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; GUINEA PIG; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS REPLICATION;

EID: 10744228374     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020301400405     Document Type: Article

References (38)

1. Alenius S (1980) Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds. Archives of Virology 65:149-156.
2. Alenius S, Berg M, Broberg F, Eklind K, Lindborg B & Oberg B (1982) Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs. Journal of Infectious Diseases 145:569-573.
3. Alenius S & Oberg B (1978) Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. Archives of Virology 58:277-288.
4. Altman D (1991). Practical Statistics for Medical Research. Oxford University Press, Oxford.
5. Aulton ME, Ed. (1988) Pharmaceutics: the Science of Dosage Form Design. Churchill Livingstone, London.
6. Awan A, Harmenberg J, Flink O & Field H (1998a) Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antiviral Chemistry & Chemotherapy 9: 19-24.
7. Awan AR, Harmenberg J, Kristofferson A & Field HJ (1998b) Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease. Antiviral Research 38:43-53.
8. Blyth WA, Harbour DA & Hill TJ (1984) Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. Journal of General Virology 65:1477-1486.
9. Corey L, Benedetti JK, Critchlow CW, Remington MR, Winter CA, Fahnlander AL, Smith K, Salter DL, Keeney RE, Davis LG, Hintz MA Connor JD & Holmes KK (1982a) Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. American Journal of Medicine 73:326-334.
10. Corey L, Nahmias AJ, Guinan ME, Benedetti JK, Critchlow CW & Holmes KK (1982b) A trial of topical acyclovir in genital herpes simplex virus infections. New England Journal of Medicine 306: 1313-1319.
11. Evans TG, Bernstein DI, Raborn GW, Harmenberg J, Kowalski J & Spruance SL (2002) Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1%, hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 46:1870-1874.
12. Field HJ, Bell SE, Elion GB, Nash AA & Wildy P (1979) Effect of acycloguanosine treatment on the acute and latent herpes simplex infection in mice. Antimicrobial Agents & Chemotherapy 15: 554-561.
13. Field HJ, Tewari D, Sutton D & Thackray AM (1995) Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppressed model. Antimicrobial Agents and Chemotherapy 39:1114-1119.
14. Freeman DJ, Sheth NV & Spruance SL (1986) Failure of topical acyclovir in ointment to penetrate human skin. Antimicrobial Agents & Chemotherapy 29:730-732.
15. Freeman DJ & Spruance SL (1986) Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. Journal of Infectious Diseases 153:64-70.
16. Hardwicke MA & Schaffer PA (1995) Cloning and characterization of herpes simplex virus type 1 oriL: comparison of replication and protein-DNA complex formation by oriL and oriS. Journal of Virology 69:1377-1388.
17. Hardwicke MA & Schaffer PA (1997) Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells. Journal of Virology 71:3580-3587.
18. Harmenberg J (1983) Intracellular pools of thymidine reduce the antiviral action of acyclovir. Intervirology 20:48-51.
19. Harmenberg J, Wahren B & Oberg B (1980) Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology 14:239-44.
20. Hill TJ, Field HJ & Blyth WA (1975) Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28: 341-353.
21. Hubler WR Jr, Felber TD, Troll D & Jarratt M (1974) Guinea pig model for cutaneous herpes simplex virus infection. Journal of Investigative Dermatology 62:92-95.
22. McKeough MB & Spruance SL (2001) Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Archives of Dermatology 137:1153-1158.
23. Nagafuchi S, Oda H, Mori R & Taniguchi T (1979) Mechanism of acquired resistance to herpes simplex virus infections as studied in nude mice. Journal of General Virology 44:715-723.
24. Nishiyama Y & Rapp F (1979) Regulation of persistent infection with herpes simplex virus in vitro by hydrocortisone. Journal of Virology 31:841-844.
25. Notter MF & Docherty JJ (1978) Steroid hormone alteration of herpes simplex virus type 1 replication. Journal of Medical Virology 2: 247-252.
26. Poli G, Dall'Ara P, Binda S, Santus G, Poli A, Cocilovo A & Ponti W (2001) Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease. Arzneimittelforschung 51:433-438.
27. Raborn GW, Martel AY, Lassonde M, Lewis MA, Boon R & Spruance SL (2002) Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. Journal of the American Dental Association 133:303-309.
28. Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG, Ashikaga T & Dolin R (1983) Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. Journal of Infectious Diseases 147:336-340.
29. Richards DM, Carmine AA, Brogden RN, Heel RC, Speight TM & Avery GS (1983) Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 26:378-438.
30. Spruance SL (1992) The natural history of recurrent oral-facial herpes simplex virus infection. Seminars in Dermatology 11:200-206.
31. Spruance SL & Crumpacker CS (1982) Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit. American Journal of Medicine 73:315-319.
32. Spruance SL, Freeman DJ & Sheth NV (1986) Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection. Antimicrobial Agents & Chemotherapy 30:196-198.
33. Spruance SL & McKeough MB (2000) Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. Journal of Infectious Diseases 181:1906-1910.
34. Spruance SL, McKeough MB & Cardinal JR (1984) Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrobial Agents & Chemotherapy 25:10-15.
35. Spruance SL, Nett R, Marbury T, Wolff R, Johnson J & Spaulding T (2002) Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents & Chemotherapy 46: 2238-2243.
36. Spruance SL, Overall JC, Jr., Kern ER, Krueger GG, Pliam V & Miller W (1977) The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. New England Journal of Medicine 297:69-75.
37. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R & Boon R (1997) Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. Journal of the American Medical Association 277:1374-1379.
38. Spruance SL, Schnipper LE, Overall JC, Jr., Kern ER, Wester B, Modlin J, Wenerstrom G, Burton C, Arndt KA, Chiu GL & Crumpacker CS (1982) Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. Journal of Infectious Diseases 146:85-90.